Home  >  Blog  >  Snakebite in Small Animals: Advice to Clinicians
Snakebite in Small Animals: Advice to Clinicians

Snakebite in Small Animals: Advice to Clinicians

Snake envenomation can look deceptively mild at first and then deteriorate quickly. This page distils our emergency and critical care team’s guidance into a rapid, practical reference. 

Outcomes are unpredictable; stable patients can crash, and severe cases can still recover - so the focus here is on early objective monitoring, airway protection where indicated, and clear triggers for transfer if intensive care is needed. 

VSOS provides 24/7 specialist oversight, ICU monitoring, invasive ventilation, and ambulance transfer from your Veterinary practice (including for anaesthetised patients). Use the checklist below to streamline decision-making, set owner expectations, and avoid delays that can cost patients their best window for a good outcome.

Triage and the first hour

  • If a bite is suspected but unconfirmed:
    • Coagulation tests (PT/aPTT).
    • CK (creatinine kinase).
    • Collect urine (>  2 h & < 12 h from bite) fora Snake Venom Detection Kit. A
      negative does not rule out envenomation?
    • If all negative - Monitor in hospital and reassess all test in 1 - 4 hrs

Presentations

  •  
  1. No clinical signs, but owner suspects possible snake bite.
  2. Preparalytic signs witnessed by owner but appears stable now
  3. Moderate clinical signs -Weakness, ataxia, reduced responsiveness, laboured breathing, nausea, pupil dilation, tachycardia, pain, mild cutaneous bruising.
  4. Severe signs - Collapse, very poor responsiveness, discoloured urine, severe myalgia/tremoring, seizures, severe laboured breathing, hypercapnia, failing ventilation, hypoxia, severe bruising, petechiae, ecchymoses.
  •  

Antivenom: selection and approach

  •  
  • Venomous snakes in New South Wales are the Eastern Brown Snake, Tiger Snake, Red Bellied Black Snake and Death Adder.
  • Multivalent Tiger/Brown antivenom is effective at neutralising Tiger, Brown and Red Bellied Black Snake venom.

  • Death adder antivenoms are not routinely stocked local requires a specific antivenom from human hospitals.

  • When to give:

    • Confirmed, witnessed envenomation or evolving coagulopathy/clinical signs supportive of snake envenomation.

    • If the bite is uncertain. Admit, observe and repeat PT/aPTT, CK and SVDK.

    • Mild/moderate signs - Give 1-2 vials and monitor for progression.

    • Severe signs - Given 2 vials straight away. May require 4-8 vials total depending on progression of signs.

  • Cats - Not all cats receive antivenom by default; timing and presentation guide the decision. Cats have much higher resistance to envenomation than dogs and so can survive without antivenom (~ 50 - 70% survival).

Monitoring and complications

  • Coagulopathy/bleeding: skin, cavities, lungs.
  • Renal risk: track creatinine and its trend (AKI concern, particularly with browns).
  • Respiratory failure: some cases require ventilatory support.
  • Prognosis messaging: unpredictable, stable can crash; severe can recover. Set expectations early.

Species/venom patterns to expect

Eastern Brown Snake (Pseudonaja spp.)

Major toxin effects: potent procoagulant (VICC), neurotoxin (progressive paralysis), cardiovascular collapse. 

Common clinical signs:

  • Sudden collapse, often with a “collapse ? apparent recovery ? deterioration” pattern
  • Weakness, ataxia, hindlimb wobbliness
  • Tachycardia initially; may later become bradycardic pre-arrest
  • Vomiting, salivation, restlessness
  • Coagulopathy: bleeding from venepuncture sites, mucosal bleeding (though less commonly than RBBS)
  • Dilated pupils, reduced menace
  • Respiratory difficulty, progressing to respiratory failure
  • Death can occur rapidly (as little as 30-60 min in severe cases without treatment)

Tiger Snake (Notechis spp.)

Major toxin effects: potent presynaptic neurotoxin (LMN flaccid paralysis), procoagulant venom (VICC), myotoxin (rhabdomyolysis)

Common clinical signs:

  • Flaccid paralysis, starting with hindlimbs and moving forward
  • Dilated, unresponsive pupils (early and prominent)
  • Difficulty swallowing, drooling, regurgitation
  • Voice change, weak or altered bark
  • Coagulopathy: prolonged clotting times, bleeding tendency
  • Muscle tremors, fasciculations
  • Dark urine (myoglobin)
  • Respiratory paralysis is the usual cause of death if untreated
  • Often more neurotoxic signs than RBBS, and more bleeding compared with brown snake in dogs

Red-Bellied Black Snake (Pseudechis porphyriacus

Major toxin effects: myotoxin (rhabdomyolysis), anticoagulant (bleeding), haemolysin (haemolysis

Common clinical signs:

  • Local swelling atbite site (more common than in brown snake bites)
  • Dark red or brown urine (myoglobinuria from muscle breakdown)
  • Vomiting, hypersalivation
  • Weakness, hindlimb ataxia (less sudden collapse than brown snakes)
  • Muscle pain, stiffness
  • Coagulopathy, though usually milder than brown and tiger snakes
  • Acute kidney injury secondary to myotoxicity
  • Respiratory compromise in severe cases
  • Dogs often survive longer before collapse than with brown snake envenomation

Death Adder (Acanthophis spp.)

Major toxin effects: extremely potent postsynaptic neurotoxin (LMN paralysis).

Common clinical signs:

  • Rapid-onset LMN flaccid paralysis
  • Marked cranial nerve signs:
    • dilated pupils
    • absent menace
    • decreased gag reflex
    • drooling
  • Weakness - recumbency - complete paralysis
  • Minimal or no bleeding disorders
  • No major myolysis (urine usually not discoloured)
  • Respiratory failure due to paralysis (primary cause of death)

Owner communication (brief)

  •  
  • Explain the unpredictable course & importance of early antivenom therapy.
  • Discuss need for serial coagulation tests, possible antivenom, and monitoring for bleeding, AKI, and respiratory compromise.
  • Prepare for potential ICU-level care and, in some cases, ventilation.
  •  

When to escalate to VSOS

  • Evidence of respiratory compromise, creatinine/AKI, progressive coagulopathy
  • Unclear antivenom strategy/availability
  • Anticipated need for continuos ICU monitoring, blood transfusions or mechanical ventilation
VSOS
Welcome Here
Visit Us at